Observational Study
Copyright ©The Author(s) 2023.
World J Gastroenterol. Apr 28, 2023; 29(16): 2502-2514
Published online Apr 28, 2023. doi: 10.3748/wjg.v29.i16.2502
Figure 2
Figure 2 Association of presepsin and acylcarnitines with 28-d survival in acute cholangitis. A-C: 28-d survival showed significant correlation with presepsin (A), acetyl-L-carnitin (C2; B), and hydroxydodecenoyl-L-carnitine (C12:1 OH; C); D: Receiver operating characteristic curves of presepsin, C2, C12:1 OH and sequential organ failure assessment score for predicting 28-d mortality in patients with acute cholangitis; E: Kaplan–Meier survival curves showed that patients with C2 Levels > 17.07 μmol/L had a lower probability of survival at 28 d (log-rank = 25.01; P < 0.001) compared to patients with lower levels in acute cholangitis. C2: Acetyl-L-carnitine; C12:1 OH: Hydroxydodecenoyl-L-carnitine; SOFA: Sequential organ failure assessment; AUC: Area under the curve.